Skip to main content

Investors Grab CHRS Even Cheaper Than Its Secondary Stock Offering

Looking back to 36 days ago, Coherus BioSciences Inc (CHRS) priced a 5,172,413 share secondary stock offering at $14.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.